MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.acra.2016.09.003

Медицинская библиотека · Academic radiology · 2016

A Study of the Feasibility of FDG-PET/CT to Systematically Detect and Quantify Differential Metabolic Effects of Chronic Tobacco Use in Organs of the Whole Body-A Prospective Pilot Study.

Torigian Drew A, Green-McKenzie Judith, Liu Xianling, Shofer Frances S, Werner Thomas, Smith Catherine E, Strasser Andrew A, Moghbel Mateen C, Parekh Ami H, Choi Grace, Goncalves Marcus D, Spaccarelli Natalie, Gholami Saied, Kumar Prithvi S, Tong Yubing, Udupa Jayaram K, Mesaros Clementina, Alavi Abass

СтатьяПеревод пока не подготовлен

Аннотация

RATIONALE AND

OBJECTIVES

The aim of this study was to assess the feasibility of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) to systematically detect and quantify differential effects of chronic tobacco use in organs of the whole body.

MATERIALS AND

METHODS

Twenty healthy male subjects (10 nonsmokers and 10 chronic heavy smokers) were enrolled. Subjects underwent whole-body FDG-PET/CT, diagnostic unenhanced chest CT, mini-mental state examination, urine testing for oxidative stress, and serum testing. The organs of interest (thyroid, skin, skeletal muscle, aorta, heart, lung, adipose tissue, liver, spleen, brain, lumbar spinal bone marrow, and testis) were analyzed on FDG-PET/CT images to determine their metabolic activities using standardized uptake value (SUV) or metabolic volumetric product (MVP). Measurements were compared between subject groups using two-sample t tests or Wilcoxon rank-sum tests as determined by tests for normality. Correlational analyses were also performed.

RESULTS

FDG-PET/CT revealed significantly decreased metabolic activity of lumbar spinal bone marrow (MVPmean: 29.8 ± 9.7 cc vs 40.8 ± 11.6 cc, P = 0.03) and liver (SUVmean: 1.8 ± 0.2 vs 2.0 ± 0.2, P = 0.049) and increased metabolic activity of visceral adipose tissue (SUVmean: 0.35 ± 0.10 vs 0.26 ± 0.06, P = 0.02) in chronic smokers compared to nonsmokers. Normalized visceral adipose tissue volume was also significantly decreased (P = 0.04) in chronic smokers. There were no statistically significant differences in the metabolic activity of other assessed organs.

CONCLUSIONS

Subclinical organ effects of chronic tobacco use are detectable and quantifiable on FDG-PET/CT. FDG-PET/CT may, therefore, play a major role in the study of systemic toxic effects of tobacco use in organs of the whole body for clinical or research purposes.

Для цитирования: Torigian Drew A, Green-McKenzie Judith, Liu Xianling, Shofer Frances S, Werner Thomas, Smith Catherine E, Strasser Andrew A, Moghbel Mateen C, Parekh Ami H, Choi Grace, Goncalves Marcus D, Spaccarelli Natalie, Gholami Saied, Kumar Prithvi S, Tong Yubing, Udupa Jayaram K, Mesaros Clementina, Alavi Abass. A Study of the Feasibility of FDG-PET/CT to Systematically Detect and Quantify Differential Metabolic Effects of Chronic Tobacco Use in Organs of the Whole Body-A Prospective Pilot Study.. Academic radiology. 2016. DOI: 10.1016/j.acra.2016.09.003.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.